We then assessed the effect of these mutants in mammalian systems, including mouse models, and LGMDD1 patient fibroblasts, where we analyzed the aggregation of TDP-43, an RNA binding protein with a prion-like domain that is a marker of degenerative disease including LGMDD1. This evidence concerns the gene DNAJB6 and neurodegenerative disease.